Millennium Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
VPM
VCM
CC
PM
Millennium Management's PRCT Position: Q1 2026 in Review
Millennium Management increased its Procept Biorobotics (PRCT) stake by 162% in Q1 2026, buying an estimated $17.5M and bringing the position to 1,005,458 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #1355.
Millennium Management first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $31.6M in Q1 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.
- Millennium Management held 1,005,458 shares of Procept Biorobotics worth $25.1M as of Q1 2026.
- Millennium Management bought 622,321 Procept Biorobotics shares in Q1 2026, an estimated $17.5M.
- Procept Biorobotics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1355 holding.
- Millennium Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
- Millennium Management's Procept Biorobotics position peaked at $31.6M in Q1 2025.
- 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.